SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-163962
Filing Date
2022-05-31
Accepted
2022-05-31 16:18:11
Documents
17
Period of Report
2022-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d310238d8k.htm   iXBRL 8-K 36337
2 EX-4.1 d310238dex41.htm EX-4.1 65039
3 EX-10.1 d310238dex101.htm EX-10.1 194891
4 EX-10.2 d310238dex102.htm EX-10.2 78597
5 EX-99.1 d310238dex991.htm EX-99.1 6861
9 GRAPHIC g310238g0527221058997.jpg GRAPHIC 3219
  Complete submission text file 0001193125-22-163962.txt   604419

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rapt-20220524.xsd EX-101.SCH 2849
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20220524_lab.xml EX-101.LAB 17980
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20220524_pre.xml EX-101.PRE 11254
11 EXTRACTED XBRL INSTANCE DOCUMENT d310238d8k_htm.xml XML 3355
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 22983495
SIC: 2834 Pharmaceutical Preparations